Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	1,019	645.05	38.28	254.32	171.48
Short-Term Investments	-	151.86	-	20.27	120.35
Trading Asset Securities	172.39	533.55	234.96	-	20.34
Cash & Short-Term Investments	1,191	1,330	273.24	274.6	312.17
Cash Growth	-	386.93%	-0.50%	-12.04%	-
Accounts Receivable	56.73	29.63	22.45	22.2	6.09
Other Receivables	1.08	24.3	15.24	12.24	3.54
Receivables	57.81	53.92	37.69	34.43	9.63
Inventory	51.73	56.1	35.33	24.8	28.37
Total Current Assets	1,552	1,440	346.26	333.83	350.17
Property, Plant & Equipment	289.81	328.42	309.55	129.53	16.63
Long-Term Investments	19.65	43.67	50.89	20	-
Other Intangible Assets	27.47	0.13	-	-	-
Long-Term Deferred Tax Assets	6.66	4.42	5.87	9.42	24.78
Other Long-Term Assets	68.94	29.58	43.26	68.76	29.38
Total Assets	1,966	1,847	755.82	561.54	420.96

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	25.43	15.86	15.78	2.8	3.11
Accrued Expenses	3.55	77.48	52.52	37.12	15.83
Current Portion of Long-Term Debt	-	83.98	23.12	9.6	48.45
Current Portion of Leases	-	1.62	1.51	1.44	0.87
Current Income Taxes Payable	10.97	8.85	5.08	-	0.01
Current Unearned Revenue	0.94	1.91	8.05	0.26	1.98
Other Current Liabilities	109.22	38.58	76.02	65.82	19.84
Total Current Liabilities	226.7	228.28	182.07	117.04	90.09
Long-Term Debt	-	19.77	26.62	31.92	35.95
Long-Term Leases	4.21	4.78	5.62	7.14	6.91
Long-Term Unearned Revenue	48.34	0.14	0.17	0.2	0.23
Total Liabilities	297.05	252.97	214.49	156.3	133.18

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	78.71	78.71	67.21	67.21	67.21
Retained Earnings	512.67	431.62	254.59	118.51	1.06
Comprehensive Income & Other	1,083	1,083	219.53	219.53	219.51
Shareholders' Equity	1,669	1,594	541.33	405.25	287.78
Total Liabilities & Equity	1,966	1,847	755.82	561.54	420.96

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	80.8	110.15	56.88	50.09	92.18
Net Cash (Debt)	1,111	1,220	216.36	224.51	219.99
Net Cash Growth	-	464.03%	-3.63%	2.05%	-
Net Cash Per Share	14.78	17.56	3.22	3.34	3.42
Filing Date Shares Outstanding	78.69	78.71	67.21	67.21	64.27
Total Common Shares Outstanding	78.69	78.71	67.21	67.21	64.27
Working Capital	1,326	1,212	164.19	216.79	260.09
Book Value Per Share	21.21	20.25	8.05	6.03	4.48
Tangible Book Value	1,642	1,594	541.33	405.25	287.78
Tangible Book Value Per Share	20.86	20.25	8.05	6.03	4.48
Buildings	-	183.11	-	-	-
Machinery	-	95.25	25.87	24.51	19.76
Construction In Progress	-	36.27	263.2	80.08	-
Leasehold Improvements	-	3.09	3.09	2.72	2.72

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error